Article Details

ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final ...

Retrieved on: 2021-02-08 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final .... View article details on hiswai:

Excerpt

The Independent Data Monitoring Committee (IDMC) recommends trial to continue to final analysis, expected in Q4 2021; No safety issues identified, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up